BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in TNXP — Tonix Pharmaceuticals Holding Corp.

CIK 1107261 HOUSTON, TX

Position in TNXP

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$255,200

+$207,083 QoQ

Shares Held

20,000

+999900.0% QoQ

Ownership

0.117%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#41

of 103 holders

Holding Since

Jun 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $87,985,615 across 108 Biotechnology names. TNXP ranks #73 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GLUE	Monte Rosa Therapeutics, Inc.	552,566	$13,372,097
2	INVA	Innoviva, Inc.	350,253	$7,954,245
3	PBYI	Puma Biotechnology, Inc.	791,616	$6,420,005
4	RIGL	Rigel Pharmaceuticals Inc	124,184	$4,858,078
5	EXEL	Exelixis, Inc.	66,100	$3,596,501
6	CRMD	CorMedix Inc.	434,132	$3,407,936
7	KROS	Keros Therapeutics, Inc.	265,017	$2,835,681
8	PTCT	Ptc Therapeutics, Inc.	22,000	$1,794,540

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$255,200	20,000	-34.3%	Shares	Sole	2026-08-14
2022-06-30	$48,117	30,454	+110.0%	Shares	Sole	2022-08-15
2022-03-31	$3,335	14,500	0.0%	Shares	Sole	2022-05-16
2021-12-31	$5,220	14,500	0.0%	Shares	Sole	2022-02-14
2021-09-30	$8,700	14,500	-93.2%	Shares	Sole	2021-11-15
2021-06-30	$238,095	214,500	-18.9%	Shares	Sole	2021-08-16
2021-03-31	$338,560	264,500	0.0%	Shares	Sole	2021-05-17
2020-12-31	$179,860	264,500	0.0%	Shares	Sole	2021-02-16
2020-09-30	$222,180	264,500	0.0%	Shares	Sole	2020-11-16
2020-06-30	$161,345	264,500	—	Shares	Sole	2020-08-31
No filing history on record for this holder in this stock.